Clovergen is a genomic and drug discovery company and it offers computer aided drug design including molecular docking, drug target identification, drug discovery screening - small molecule screening, library screening, ion channel screening - fragment based drug design, ligand based drug design, ligand protein binding, protein ligand docking calculation and prediction, drug profiling, lead identification, lead compound identification and lead optimization.
• Virtual screening
• Protein-ligand interactions
• Validated docking models and scoring
• SAR & QSAR analysis
• Selectivity analysis
• Activity prediction
• Suggestions for synthesis / testing
• Validated pharmacophore/3D-/2D-QSAR models
• Activity prediction
• SAR & QSAR analysis
• Selectivity analysis
• Cluster analysis
• Suggestions for synthesis/ testing
• Template search
• Validated homology models
• Sequence analysis
• Structural analysis
• Comparison of homologous proteins
• Analysis of PDBs
• Compare & characterize binding sites
• PDB water analysis
• Calculate ligand properties
• Correlate activity & properties
• Chemical Enrichment Analysis
• Small Molecule Identification
• Pocket Detection
• Protein-Ligand Docking
• Protein-Protein Docking
• Chemical Translation
• Protein-Peptide Docking
• GPCR ligand Interactions
• RNA-Ligand Interactions
• Drug Pathways
• Peptides
• Natural compounds
• Proteins
• Commercial available molecules
• Synthetic small molecules,
• Sugars
For more information about working with clovergen to accelerate your insilico drug discovery and research our more advanced technology, please contact us at: clovergenls@gmail.com